Pharma News

Eli Lilly and GSK drive South Korea’s drug licensing activity

CSL's Venofer finally faces generic competition as FDA clears copycats from Viatris, Sandoz and Amphastar

Fosun Pharma’s subsidiary, Fosun Pharma Industrial, has entered a licence agreement to grant ex-China rights for its experimental respiratory drug, XH-S004, to Expedition Therapeutics.

A newer type of diabetes medication called sodium-glucose cotransporter-2 (SGLT2) inhibitors has been linked to a rare but very serious infection called Fournier gangrene.

Newron Notes the Publication of New Preclinical Research Suggesting Evenamide Ameliorates Schizophrenia-Related Dysfunction

The US Food and Drug Administration (FDA) has unveiled a new programme aimed at boosting the country’s domestic pharmaceutical supply chain.

Trade wars, tariff threats and logistics shocks are upending businesses and spreading volatility. Understand the new order of global commerce.

Dyne Therapeutics (DYN) Is Up 17.0% After FDA Grants Breakthrough Status to DYNE-251 for DMD

SAR446523 Receives FDA Orphan Drug Designation for R/R Myeloma

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

Boehringer Ingelheim breaks into oncology with FDA approval for lung cancer med Hernexeos

Genmab and AbbVie’s subcutaneous bispecific antibody Epkinly (epcoritamab) has met its dual primary endpoints as a second-line combination therapy in relapsed or refractory (r/r) fol...